| Study of WM-A1-3389 in Participants With Advanced or Metastatic Solid Tumors and Non-Small Cell Lung Cancer (MK-3475-E90/KEYNOTE-E90) (NCT05872867) | Wellmarker Bio | 2024-03-14 |
| A Study of Macitentan in Children Below 2 Years of Age (NCT05731492) | Actelion | 2024-03-14 |
| Mitigating PTSD-CUD After Sexual Assault (NCT05989841) | University of Nevada, Las Vegas | 2024-03-14 |
| Safety and Efficacy Study of NUV-1511 in Adult Patients With Advanced Solid Tumors (NCT06334432) | Nuvation Bio Inc. | 2024-03-14 |
| To Compare the Safety and PK/ PD Characteristics of ADC189 Between Hepatic Impairment and Normal Hepatic Function Subjects (NCT06485401) | Jiaxing AnDiCon Biotech Co.,Ltd | 2024-03-14 |
| Neoadjuvant ADI-PEG 20 + Ifosfamide + Radiotherapy in Soft Tissue Sarcoma (NCT05813327) | Washington University School of Medicine | 2024-03-14 |
| A Phase Ib Study of PRJ1-3024 for Treatment of Advanced or Metastatic Melanoma (NCT06727630) | Zhuhai Yufan Biotechnologies Co., Ltd | 2024-03-14 |
| TBio-4101 and Pembro wi/ or w/o Chemo in Recurrent/Metastatic HNSCC (NCT06236425) | H. Lee Moffitt Cancer Center and Research Institute | 2024-03-14 |
| A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of INCB160058 When Administered Orally to Healthy Adult Participant (NCT06213818) | Incyte Corporation | 2024-03-14 |
| First-in-Human Trial of the Novel Tuberculosis Vaccine Candidate, H107e/CAF®10b (NCT06050356) | Statens Serum Institut | 2024-03-14 |
| A Study of BRY805 in Participants With Advanced Solid Tumors (NCT06289894) | BioRay Pharmaceutical Co., Ltd. | 2024-03-13 |
| Avapritinib With Decitabine in Patients With SM-AHN (NCT06327685) | H. Lee Moffitt Cancer Center and Research Institute | 2024-03-13 |
| Double-blind Placebo Controlled Study to Evaluate the Effect of NAD+ Boosting With Nicotinamide Riboside on Immunometabolism and Immunity in Systemic Lupus Erythematosus (NCT06032923) | National Heart, Lung, and Blood Institute (NHLBI) | 2024-03-13 |
| A Study To Evaluate the Relative Bioavailability, Food Effect, and Dose Proportionality of a Granule Formulation of Vanzacaftor/Tezacaftor/Deutivacaftor(VNZ/TEZ/D-IVA) (NCT06299709) | Vertex Pharmaceuticals Incorporated | 2024-03-13 |
| LMY-920 for Treatment of Relapsed or Refractory Myeloma (NCT05546723) | Luminary Therapeutics | 2024-03-13 |
| A Study to Investigate Different Formulations of S-337395 in Healthy Adult Participants (NCT06270511) | Shionogi | 2024-03-13 |
| Vitamin D in OUD: Exploration of Alterations on the Dopamine D2/D3 Receptor System (NCT06261905) | Yale University | 2024-03-13 |
| A Study to Test Whether Multiple Doses of BI 456906 Have an Effect on Cardiac Safety in People With Overweight or Obesity (NCT06200467) | Boehringer Ingelheim | 2024-03-13 |
| Study of CM313 in Healthy Subjects (NCT06285227) | Keymed Biosciences Co.Ltd | 2024-03-12 |
| Comparative Bioavailability Study of Tablet and Granule Formulations of ADC189 and the Study of Ultra-high Dose (NCT06428903) | Jiaxing AnDiCon Biotech Co.,Ltd | 2024-03-12 |
| The Use of Botulinum Toxin in the Management of Myofascial Pain Syndrome (NCT06824324) | Yassir R. Al-khannaq | 2024-03-12 |
| Opioid Free Anesthesia in Shoulder Arthroscope (NCT06834854) | Ain Shams University | 2024-03-12 |
| Study of AZD0754 in Participants With Metastatic Prostate Cancer (NCT06267729) | AstraZeneca | 2024-03-12 |
| First-in-Human Study of LPM6690176 in Patients With Advanced Solid Tumors. (NCT06240546) | Luye Pharma Group Ltd. | 2024-03-12 |
| A Study of IBI129 in Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors (NCT05991349) | Innovent Biologics (Suzhou) Co. Ltd. | 2024-03-12 |
| Studies Evaluating the Effects of Itraconazole or Rifampicin on the Pharmacokinetics of TY-9591 Tablets in Healthy Subjects (NCT06255951) | TYK Medicines, Inc | 2024-03-12 |
| Effects of Acute Exercise and Ibuprofen on Symptoms, Immunity, and Neural Circuits in Bipolar Depression (NCT06088732) | Laureate Institute for Brain Research, Inc. | 2024-03-12 |
| A Phase 1b Proof-of-concept Trial Exploring the Effects of FE 999322 and FE 999324 in Adults With Mild to Moderate Ulcerative Colitis (NCT06260267) | Ferring Pharmaceuticals | 2024-03-12 |
| A Phase 1 Study of FD-001 in Recurrent /Refractory (R/R)AML/NHL/MM/MDS (NCT06731699) | Chengdu FenDi Pharmaceutical Co., Ltd. | 2024-03-11 |
| Dose Escalation and Expansion Clinical Trial of Irinotecan Liposome Combined With Oxaliplatin and 5-FU/LV Plus Bevacizumab as First-line Treatment of Metastatic Colorectal Cancer (NCT06225622) | Shanghai Zhongshan Hospital | 2024-03-11 |
| Comparative Analysis of Biomarkers in Response to Acute Moderate-Intensity Activity (NCT06217068) | University of Georgia | 2024-03-11 |
| A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors (NCT06257264) | BeiGene | 2024-03-11 |
| Pilot Feasibility Study of Fecal Microbiota Transplant for the Treatment of Small Intestinal Bacterial Overgrowth (NCT05967871) | McMaster Children's Hospital | 2024-03-11 |
| Treating Nectin-4-positive Advanced Breast Cancer with XKDCT293 (Nectin-4-CAR-T) (NCT06724835) | Shenzhen Celconta Life Science Co., Ltd. | 2024-03-11 |
| A Phase l Study of By101921, an Oral PARP7 Inhibitor, in Patients With Advanced Solid Tumors (NCT06433726) | Chengdu Baiyu Pharmaceutical Co., Ltd. | 2024-03-11 |
| Treatment of Relapsed or Refractory B-cell Lymphoma With Chimeric Antigen Receptor (CAR) T-cell Therapy Produced by a New Technology (NCT06378190) | Instituto de Investigación Biomédica de Salamanca | 2024-03-11 |
| Pharmacokinetics and Pharmacodynamics of Edoxaban Before and After Bariatric Surgery (NCT06326138) | Institut universitaire de cardiologie et de pneumologie de Québec, University Laval | 2024-03-11 |
| Combination of Cardonizumab Injection and TKI Second Line Therapy for Advanced Hepatocellular Cancer (NCT06363006) | Peking Union Medical College Hospital | 2024-03-11 |
| A Study in Healthy Men to Test How Different Doses of BI 3031185 Are Tolerated and How Food Influences the Amount of BI 3031185 in the Blood (NCT06255340) | Boehringer Ingelheim | 2024-03-11 |
| Polypill for Prevention of Cardiomyopathy (NCT06143566) | University of Texas Southwestern Medical Center | 2024-03-11 |
| Oral Nicorandil for Prevention of No Reflow Phenomenon in Anterior STEMI Patients Undergoing PPCI (NCT07138508) | Ain Shams University | 2024-03-10 |
| SOX Combined With Tislelizumab and LDRT for Neoadjuvant Treatment of Locally Advanced Gastric Cancer (NCT06266871) | West China Hospital | 2024-03-10 |
| The Bioequivalence Study of Alfuzosin 10 mg Prolong-released Tablets Under Fed Conditions (NCT06228339) | International Bio service | 2024-03-09 |
| A Clinical Trial to Evaluate Effect of IBD0333 in Patients With Advanced Malignant Tumors (NCT06292208) | SUNHO（China）BioPharmaceutical CO., Ltd. | 2024-03-09 |
| A Study to Assess Adverse Events, and How Intravenously (IV) Infused ABBV-969 Moves Through the Bodies of Adult Participants With Metastatic Castration-Resistant Prostate Cancer (NCT06318273) | AbbVie | 2024-03-08 |
| A Study of NBL-028 in Patients With Advanced Solid Tumors (NCT06223256) | NovaRock Biotherapeutics, Ltd | 2024-03-08 |
| Investigating the Mechanisms of the Effects of Psilocybin on Visual Perception and Visual Representations in the Brain (NCT05265546) | University of California, Berkeley | 2024-03-08 |
| Intradermal Ipilimumab and Nivolumab in High Risk Stage II Melanoma (NCT06240143) | The Netherlands Cancer Institute | 2024-03-08 |
| A Study of AMG 355 Alone and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors (NCT06131398) | Amgen | 2024-03-07 |
| Bioequivalence Assessment Between Two Perampanel Oral Suspension Formulations (NCT06969963) | Aya Mohammed Abdel Magid Abdel Hamid | 2024-03-07 |
| Delayed or Upfront Brain RAdiotherapy in Treatment naïve Lung Cancer Patients With Asymptomatic or Minimally Symptomatic Brain Metastases and ALK rEarrangements (NCT05987644) | Joshua Palmer | 2024-03-07 |
| A Study Investigating the Safety, Absorption, and Elimination of MB04, a New Compound That May Potentially be Used in the Treatment of Autoimmune Disorders (NCT06392074) | mAbxience Research S.L. | 2024-03-07 |
| Phase 1 Study to Evaluate Safety, Tolerability and Pharmacokinetics/-Dynamics of AK1967 (Procizumab) (NCT06331884) | 4TEEN4 Pharmaceuticals GmbH | 2024-03-07 |
| Pharmacokinetics of Afamelanotide in Erythropoietic Protoporphyria Patients (NCT06388642) | Clinuvel Europe Limited | 2024-03-07 |
| Phase I Clinical Study: BG1805 Injection in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia (NCT06118788) | Guangzhou Bio-gene Technology Co., Ltd | 2024-03-07 |
| First-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC) (NCT06217822) | Bayer | 2024-03-07 |
| A Phase Ia/Ib Open-label, Multiple Dose, Study to Determine the Recommended Dose, Evaluate PKs, PDs, Safety, and Activity of Venetoclax in Combination With Oral Decitabine/Cedazuridine (ASTX727) in Pediatric Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) (NCT06191978) | M.D. Anderson Cancer Center | 2024-03-07 |
| Study of 23ME-01473 in Patients With Advanced Solid Malignancies (NCT06290388) | 23andMe, Inc. | 2024-03-07 |
| PSMA PET Response Guided SabR in High Risk Pca (NCT06044857) | University of Texas Southwestern Medical Center | 2024-03-07 |
| A Study for HSK39775 in Participants With Solid Tumors (NCT06314373) | Xizang Haisco Pharmaceutical Co., Ltd | 2024-03-07 |
| Allogenic Mesenchymal Stem Cell Intraarticular Injection for Knee Osteoarthritis Therapy (NCT05933434) | Aarhus University Hospital | 2024-03-07 |
| Biodistribution & Pharmacokinetic of Position Emission Tomography (PET) Radiopharmaceutical 18F C SNAT4 (NCT04017819) | Stanford University | 2024-03-07 |
| Nicotinamide Riboside (NR) to Treat Moyamoya-like Cerebrovascular Disease in Smooth Muscle Dysfunction Syndrome (SMDS) (NCT06280482) | The University of Texas Health Science Center, Houston | 2024-03-06 |
| A Study to Investigate the Potential Drug-Drug Interaction Between VH4524184 and Oral Contraceptive (Loestrin) in Healthy Adult Female Participants (NCT06310616) | ViiV Healthcare | 2024-03-06 |
| Fecal Microbiota Transplantation for Patients With Autism Spectrum Disorder. (NCT06290258) | Chang Gung Memorial Hospital | 2024-03-06 |
| Mitigation of Arthrofibrosis After Total Knee Arthroplasty Using Losartan (NCT06108063) | Steadman Philippon Research Institute | 2024-03-06 |
| Thiotepa, Cyclophosphamide, Clarithromycin and Cytarabine (NCT06060782) | Fifth Affiliated Hospital, Sun Yat-Sen University | 2024-03-06 |
| Safety and Pharmacokinetics of Subcutaneous Dose of IMG-007 in Healthy Participants (NCT06304740) | Inmagene LLC | 2024-03-06 |
| Effect of Halotherapy in Children With Asthma (NCT06250452) | Igdir University | 2024-03-06 |
| A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986326 in Participants With Atopic Dermatitis (NCT06248814) | Bristol-Myers Squibb | 2024-03-06 |
| A Study in Healthy People to Test Whether Different Doses of BI 1015550 Have Potential to Induce Heart Rhythm Abnormalities (NCT06107036) | Boehringer Ingelheim | 2024-03-06 |
| Construction and Clinical Translation of ACE Targeted Nuclear Medicine Imaging Probe (NCT06203119) | Peking University Cancer Hospital & Institute | 2024-03-06 |
| A Study of MGC026 in Participants With Advanced Solid Tumors (NCT06242470) | MacroGenics | 2024-03-06 |
| A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Multiple Oral Doses (6 Days) of 100 mg Resmetirom in Subjects With Severe Renal Impairment and in Matched Healthy Control Subjects With Normal Renal Function (NCT06397872) | Madrigal Pharmaceuticals, Inc. | 2024-03-06 |
| Bioequivalence Study of Ivermectin 1% Cream and Soolantra (Ivermectin) 10 mg/g Cream (NCT06557603) | Humanis Saglık Anonim Sirketi | 2024-03-06 |
| A First-in-Human Study to Learn How Well a Bi-Layer Calcium Carbonate Antacid Tablet Works Compared to a Standard, Non-Layered Calcium Carbonate Tablet in Healthy Male Participants (NCT06293326) | Bayer | 2024-03-06 |
| Assessment of Safety, Tolerability and Pharmacokinetics With BAT4706 and BAT1308 in Advanced Solid Tumors Patients (NCT06139536) | Bio-Thera Solutions | 2024-03-06 |
| TGRX-814 Chinese Phase I/II in Patients With Hematological Malignancies (NCT06206174) | Shenzhen TargetRx Co., Ltd. | 2024-03-06 |
| Study of Single Doses of SBT777101 in Subjects With Rheumatoid Arthritis (NCT06201416) | Sonoma Biotherapeutics, Inc. | 2024-03-06 |
| Phase I Study of Autologous CD8+ and CD4+ Engineered T Cell Receptor T Cells in Subjects With Advanced or Metastatic Solid Tumor (NCT06105021) | Affini-T Therapeutics, Inc. | 2024-03-06 |
| A Phase Ib/II Clinical Study of GH21 Capsules Combined With Osimertinib Mesylate Tablets in Patients With NSCLC (NCT06306456) | Suzhou Genhouse Bio Co., Ltd. | 2024-03-05 |
| A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment (NCT06239116) | Rhythm Pharmaceuticals, Inc. | 2024-03-05 |
| Testing the Addition of Immunotherapy With Hu5F9-G4 (Magrolimab) to the Usual PARP Inhibitor, Olaparib for Treatment of Metastatic or Recurrent Breast or Castrate-Resistant Prostate Cancer With BRCA Mutations (NCT05807126) | National Cancer Institute (NCI) | 2024-03-05 |
| Title: Leveraging Technology to Address Health Outcomes of Cancer Survivors (NCT05499663) | University of Maryland, Baltimore | 2024-03-05 |
| A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors (NCT06238479) | Eli Lilly and Company | 2024-03-05 |
| A Study to Investigate the Pharmacokinetic/Pharmacodynamic Characteristics of IBI128(A New Xanthine Oxidase Inhibitor) (NCT06277752) | Innovent Biologics (Suzhou) Co. Ltd. | 2024-03-05 |
| Pharmacokinetics of Intravenous and Intranasal Formulations of Naloxone in Healthy Volunteers. (NCT06306391) | Parc de Salut Mar | 2024-03-05 |
| Drospirenone (3 mg) + Ethinyl Estradiol (0.03 mg) Tablets Relative to Yasmin® (NCT06233058) | Bio-innova Co., Ltd | 2024-03-05 |
| Donor Immune Cells (TGFbi NK Cells) and Isatuximab for the Treatment of Relapsed or Refractory Multiple Myeloma (NCT06203912) | Elvira Umyarova | 2024-03-05 |
| Safety, Tolerability and Efficacy of VUM02 Injection in Treatment of Idiopathic Pulmonary Fibrosis (IPF) (NCT06230822) | Wuhan Optics Valley Vcanbiopharma Co., Ltd. | 2024-03-05 |
| A Study of Carbon-14-Labelled [14C] LY3473329 in Healthy Male Participants (NCT06342596) | Eli Lilly and Company | 2024-03-05 |
| A First-in-Human SAD/MAD Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ENC1018 in Healthy Adult Subjects (NCT06224400) | EnnovaBio Australia Pharmaceuticals Pty Ltd | 2024-03-05 |
| Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors (NCT06256055) | UTC Therapeutics Inc. | 2024-03-05 |
| A Study to Compare the Pharmacokinetics and the Safety Between a Fixed-dose Combination Administration of "BR3005" and Co-administration of "BR3005-1" and "BR3005-2" Under Fed Conditions in Healthy Adult Volunteers (NCT06289933) | Boryung Pharmaceutical Co., Ltd | 2024-03-05 |
| First-in-human Dose Escalation and Expansion Study With the SIRPα-directed Monoclonal Antibody BYON4228 (NCT05737628) | Byondis B.V. | 2024-03-04 |
| A Study to Investigate the Safety, Tolerability, and Pharmacokinetics and Pharmacodynamics Following Subcutaneous Injections of PG-102 (MG12) in Healthy Adult and Obesity Participants. (NCT06309667) | ProGen. Co., Ltd. | 2024-03-04 |
| TGRX-326 Pharmacokinetic Drug Interaction (NCT06294561) | Shenzhen TargetRx Co., Ltd. | 2024-03-04 |
| Safety, Tolerability and Pharmacokinetics of LNZ101 and LNZ100 Ophthalmic Solutions in Healthy Adult Chinese With Presbyopia (NCT06270030) | Corxel Pharmaceuticals | 2024-03-04 |
| TP-3654 Food Effect Study (NCT07492355) | Sumitomo Pharma America, Inc. | 2024-03-04 |
| Safety, Tolerability, and Efficacy of Immunomodulation With A Monoclonal Antibody Against CD40L in Combination With Transplanted Islet Cells in Adults With Brittle Type 1 Diabetes Mellitus (T1D) (NCT06305286) | University of Chicago | 2024-03-04 |